BEAM earnings: a positive outcome, +25.9%

On February 27, 2024, Beam Therapeutics Inc. reached its earnings. The result was a positive outcome, and the stock moved +25.9% in the window around the event. It had already run +39.9% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.